Abstract:Abstract. 177 Lu is a medium energy beta-emitter commonly used in Nuclear Medicine for radiotherapeutic applications. In this work, the half-life of 177 Lu has been measured using a re-entrant ionisation chamber over a period of 82 days (approximately 12 half-lives). Unlike the majority of previous studies, the material used in this work was produced via the 176 Yb(n,γ ) 177 Yb reaction followed by the β-decay to 177 Lu, producing insignificant quantities of 177m Lu. This has resulted in the most precise half… Show more
“…iii) The undesirable 177m Lu (t 1/2 ≈160 d) is produced in the direct route, 0.05%, whereas in the indirect route it is less than 10 -5 % [16]. 177m Lu creates important problems, the urine of the patient must be treated as radioactive waste, and the patient receives an undesirable dose.…”
Section: Introductionmentioning
confidence: 99%
“…These properties have a direct impact on the quality of the diagnosis and the therapy. The higher specific activity allows a much better tumour uptake; thus, the dose deliver to tumour for the same activity is much higher in case of the indirect route, and in addition, the quality of imaging of the tumour is much better [15,16].…”
Several international agencies recommend the study of new routes and new facilities for producing radioisotopes with application to nuclear medicine. 177Lu is a versatile radioisotope used for therapy and diagnosis (theranostics) of cancer with good success in neuroendocrine tumours that is being studied to be applied to a wider range of tumours. 177Lu is produced in few nuclear reactors mainly by the neutron capture on 176Lu. However, it could be produced at high-intensity celeratorbased neutron facilities. The energy of the neutrons in accelerator-based neutron facilities is higher than in thermal reactors.Thus, experimental data on the 176Yb(n,γ) cross-section in the eV and keV region are mandatory to calculate accurately the production of 177Yb, which beta decays to 177Lu. At present, there are not experimental data available from thermal to 3 keV of the 176Yb(n,γ) cross-section. In addition, there is no data in the resolved resonance region (RRR). This contribution shows the first results of the 176Yb capture measurement performed at the n_TOF facility at CERN.
“…iii) The undesirable 177m Lu (t 1/2 ≈160 d) is produced in the direct route, 0.05%, whereas in the indirect route it is less than 10 -5 % [16]. 177m Lu creates important problems, the urine of the patient must be treated as radioactive waste, and the patient receives an undesirable dose.…”
Section: Introductionmentioning
confidence: 99%
“…These properties have a direct impact on the quality of the diagnosis and the therapy. The higher specific activity allows a much better tumour uptake; thus, the dose deliver to tumour for the same activity is much higher in case of the indirect route, and in addition, the quality of imaging of the tumour is much better [15,16].…”
Several international agencies recommend the study of new routes and new facilities for producing radioisotopes with application to nuclear medicine. 177Lu is a versatile radioisotope used for therapy and diagnosis (theranostics) of cancer with good success in neuroendocrine tumours that is being studied to be applied to a wider range of tumours. 177Lu is produced in few nuclear reactors mainly by the neutron capture on 176Lu. However, it could be produced at high-intensity celeratorbased neutron facilities. The energy of the neutrons in accelerator-based neutron facilities is higher than in thermal reactors.Thus, experimental data on the 176Yb(n,γ) cross-section in the eV and keV region are mandatory to calculate accurately the production of 177Yb, which beta decays to 177Lu. At present, there are not experimental data available from thermal to 3 keV of the 176Yb(n,γ) cross-section. In addition, there is no data in the resolved resonance region (RRR). This contribution shows the first results of the 176Yb capture measurement performed at the n_TOF facility at CERN.
“…With the enhanced rigor in experimental execution and data analysis, the metrological community is currently achieving better consistency at a higher level of accuracy than in the past. Examples of recently achieved convergence are the improved half-life values for 55 Fe [7,8], 109 Cd [9][10][11], 177 Lu [12][13][14][15][16], 209 Po [17][18][19], 225 Ac [20,21], 223 Ra [22,23], and 227 Th [24,25].…”
A least-squares fit of exponential functions to a measured radioactive decay rate curve provides an estimate of the half-life and its statistical uncertainty in the assumption that all deviations from the theoretical curve are purely of a random nature. The result may be biased and the error underestimated as soon as the experiment suffers instabilities that exceed the duration of individual measurements. Contrary to long-term systematic errors, medium-frequency cyclic perturbations may be observable as autocorrelated structures in the residuals. In this work, an empirical decomposition algorithm is used to separate medium-frequency effects from the random statistical component in the fit residuals, such that custom error propagation factors can be calculated. A theoretical study of error propagation is made for sine and square wave perturbations. The empirical decomposition method is demonstrated on a synthetic spectrum, a time series of solar neutrino detection rates, and two experimental decay curves of 134Cs measured in an ionisation chamber.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.